Serums CXCL10 and CCL2 were assayed in 60 MC + HCV patients, in 45 patients with “MC with AT” (MC + AT), and in controls (60 without (control 1) and 45 with AT (control 2)). Here, CXCL10 is linked to ataxia telangiectasia.